Insulet Quarterly Cash Flow Statement
NASDAQ: PODDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Insulet free cash flow
In the quarter ended Jun 30, 2026, Insulet generated $88.4 million of operating cash flow and spent $32.5 million on capital expenditures. That left free cash flow of $55.9 million, a free-cash-flow margin of 7.0% of revenue. Free cash flow was down 68.6% from the prior year's $177.9 million.
Summary generated from market data by MetaCap's automated system. Methodology
Insulet cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 95.00M | 91.10M | 101.60M | 87.60M | 22.50M | 35.40M | 100.70M | 77.50M | 188.60M | 51.50M | 103.30M | 51.90M |
| Net Income growth (YoY) | +322.22% | +157.34% | +0.89% | +13.03% | -88.07% | -31.26% | -2.52% | +49.33% | +590.84% | +116.39% | +507.65% | — |
| Depreciation & Amortization | 26.70M | 26.20M | 24.40M | 22.00M | 22.30M | 21.70M | 21.50M | 21.30M | 19.20M | 18.80M | 18.80M | 18.70M |
| Stock-Based Compensation | 19.60M | 21.30M | 20.30M | 16.70M | 7.50M | 18.20M | 20.00M | 18.10M | 17.00M | 14.20M | 12.70M | 10.50M |
| Change in Working Capital | -90.60M | 67.50M | -8.50M | -70.90M | 19.20M | 17.10M | -16.70M | -45.80M | -15.10M | 29.00M | -105.70M | -65.30M |
| Operating Cash Flow | 88.40M | 113.80M | 183.30M | 125.70M | 196.50M | 63.80M | 147.50M | 108.30M | 86.80M | 87.60M | 45.20M | 56.00M |
| Capital Expenditures | -32.50M | -24.30M | -135.10M | -25.60M | -18.60M | -12.30M | -53.60M | -26.70M | -22.50M | -22.10M | -29.30M | -20.10M |
| Investing Cash Flow | -37.40M | -27.70M | -152.80M | -31.00M | -23.30M | -15.60M | -68.00M | -29.30M | -24.90M | -24.00M | -31.60M | -22.60M |
| Share Repurchases | 0 | -300.00M | 0 | -29.50M | -30.10M | 0 | 0 | 0 | — | — | — | — |
| Debt Issued | 0 | 0 | 425.20M | -425.20M | 0 | 440.70M | -130.00M | 130.00M | 0 | 0 | — | — |
| Financing Cash Flow | 4.00M | -319.90M | -72.50M | -457.00M | -343.50M | 277.70M | -20.80M | -1.90M | 8.80M | -14.10M | 2.20M | -6.90M |
| Net Change in Cash | 54.50M | -235.70M | -41.40M | -364.10M | -161.50M | 329.70M | 50.70M | 81.70M | 69.80M | 47.00M | 18.70M | 25.30M |
| Free Cash Flow | 55.90M | 89.50M | 48.20M | 100.10M | 177.90M | 51.50M | 93.90M | 81.60M | 64.30M | 65.50M | 15.90M | 35.90M |
This table shows 12 quarterly periods of Insulet's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PODD's reporting calendar. What is a cash flow statement?